Export Ready — 

Structure and Aggregation Mechanisms in Amyloids

Bibliographic Details
Main Author: Almeida, Zaida L.
Publication Date: 2020
Other Authors: Brito, Rui M. M.
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://hdl.handle.net/10316/106460
https://doi.org/10.3390/molecules25051195
Summary: The aggregation of a polypeptide chain into amyloid fibrils and their accumulation and deposition into insoluble plaques and intracellular inclusions is the hallmark of several misfolding diseases known as amyloidoses. Alzheimer's, Parkinson's and Huntington's diseases are some of the approximately 50 amyloid diseases described to date. The identification and characterization of the molecular species critical for amyloid formation and disease development have been the focus of intense scrutiny. Methods such as X-ray and electron diffraction, solid-state nuclear magnetic resonance spectroscopy (ssNMR) and cryo-electron microscopy (cryo-EM) have been extensively used and they have contributed to shed a new light onto the structure of amyloid, revealing a multiplicity of polymorphic structures that generally fit the cross-β amyloid motif. The development of rational therapeutic approaches against these debilitating and increasingly frequent misfolding diseases requires a thorough understanding of the molecular mechanisms underlying the amyloid cascade. Here, we review the current knowledge on amyloid fibril formation for several proteins and peptides from a kinetic and thermodynamic point of view, the structure of the molecular species involved in the amyloidogenic process, and the origin of their cytotoxicity.
id RCAP_edcb98594642b7256bc3e7c99b97cc05
oai_identifier_str oai:estudogeral.uc.pt:10316/106460
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Structure and Aggregation Mechanisms in Amyloidsmisfolding diseasesamyloidosisoligomersaggregatesaggregationaggregation mechanismssteric zipperamyloid fibrilsamyloid structureamyloid dyesAmino Acid MotifsAmino Acid SequenceAmyloidAmyloid beta-PeptidesAnimalsComputational BiologyHumansKineticsMolecular StructureProtein BindingStructure-Activity RelationshipThermodynamicsModels, MolecularProtein AggregatesProtein Aggregation, PathologicalProtein ConformationThe aggregation of a polypeptide chain into amyloid fibrils and their accumulation and deposition into insoluble plaques and intracellular inclusions is the hallmark of several misfolding diseases known as amyloidoses. Alzheimer's, Parkinson's and Huntington's diseases are some of the approximately 50 amyloid diseases described to date. The identification and characterization of the molecular species critical for amyloid formation and disease development have been the focus of intense scrutiny. Methods such as X-ray and electron diffraction, solid-state nuclear magnetic resonance spectroscopy (ssNMR) and cryo-electron microscopy (cryo-EM) have been extensively used and they have contributed to shed a new light onto the structure of amyloid, revealing a multiplicity of polymorphic structures that generally fit the cross-β amyloid motif. The development of rational therapeutic approaches against these debilitating and increasingly frequent misfolding diseases requires a thorough understanding of the molecular mechanisms underlying the amyloid cascade. Here, we review the current knowledge on amyloid fibril formation for several proteins and peptides from a kinetic and thermodynamic point of view, the structure of the molecular species involved in the amyloidogenic process, and the origin of their cytotoxicity.The authors acknowledge funding from the Fundação para a Ciência e a Tecnologia (FCT), Portuguese Agency for Scientific Research, through project UID/QUI/00313/2019 (to Coimbra Chemistry Centre, University of Coimbra) and programs COMPETE and CENTRO-2020. Z.L.A. also thanks FCT for doctoral fellowship SFRH/BD/137991/2018.MDPI2020-03-06info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://hdl.handle.net/10316/106460https://hdl.handle.net/10316/106460https://doi.org/10.3390/molecules25051195eng1420-3049Almeida, Zaida L.Brito, Rui M. M.info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-19T17:25:27Zoai:estudogeral.uc.pt:10316/106460Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T05:57:12.563359Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Structure and Aggregation Mechanisms in Amyloids
title Structure and Aggregation Mechanisms in Amyloids
spellingShingle Structure and Aggregation Mechanisms in Amyloids
Almeida, Zaida L.
misfolding diseases
amyloidosis
oligomers
aggregates
aggregation
aggregation mechanisms
steric zipper
amyloid fibrils
amyloid structure
amyloid dyes
Amino Acid Motifs
Amino Acid Sequence
Amyloid
Amyloid beta-Peptides
Animals
Computational Biology
Humans
Kinetics
Molecular Structure
Protein Binding
Structure-Activity Relationship
Thermodynamics
Models, Molecular
Protein Aggregates
Protein Aggregation, Pathological
Protein Conformation
title_short Structure and Aggregation Mechanisms in Amyloids
title_full Structure and Aggregation Mechanisms in Amyloids
title_fullStr Structure and Aggregation Mechanisms in Amyloids
title_full_unstemmed Structure and Aggregation Mechanisms in Amyloids
title_sort Structure and Aggregation Mechanisms in Amyloids
author Almeida, Zaida L.
author_facet Almeida, Zaida L.
Brito, Rui M. M.
author_role author
author2 Brito, Rui M. M.
author2_role author
dc.contributor.author.fl_str_mv Almeida, Zaida L.
Brito, Rui M. M.
dc.subject.por.fl_str_mv misfolding diseases
amyloidosis
oligomers
aggregates
aggregation
aggregation mechanisms
steric zipper
amyloid fibrils
amyloid structure
amyloid dyes
Amino Acid Motifs
Amino Acid Sequence
Amyloid
Amyloid beta-Peptides
Animals
Computational Biology
Humans
Kinetics
Molecular Structure
Protein Binding
Structure-Activity Relationship
Thermodynamics
Models, Molecular
Protein Aggregates
Protein Aggregation, Pathological
Protein Conformation
topic misfolding diseases
amyloidosis
oligomers
aggregates
aggregation
aggregation mechanisms
steric zipper
amyloid fibrils
amyloid structure
amyloid dyes
Amino Acid Motifs
Amino Acid Sequence
Amyloid
Amyloid beta-Peptides
Animals
Computational Biology
Humans
Kinetics
Molecular Structure
Protein Binding
Structure-Activity Relationship
Thermodynamics
Models, Molecular
Protein Aggregates
Protein Aggregation, Pathological
Protein Conformation
description The aggregation of a polypeptide chain into amyloid fibrils and their accumulation and deposition into insoluble plaques and intracellular inclusions is the hallmark of several misfolding diseases known as amyloidoses. Alzheimer's, Parkinson's and Huntington's diseases are some of the approximately 50 amyloid diseases described to date. The identification and characterization of the molecular species critical for amyloid formation and disease development have been the focus of intense scrutiny. Methods such as X-ray and electron diffraction, solid-state nuclear magnetic resonance spectroscopy (ssNMR) and cryo-electron microscopy (cryo-EM) have been extensively used and they have contributed to shed a new light onto the structure of amyloid, revealing a multiplicity of polymorphic structures that generally fit the cross-β amyloid motif. The development of rational therapeutic approaches against these debilitating and increasingly frequent misfolding diseases requires a thorough understanding of the molecular mechanisms underlying the amyloid cascade. Here, we review the current knowledge on amyloid fibril formation for several proteins and peptides from a kinetic and thermodynamic point of view, the structure of the molecular species involved in the amyloidogenic process, and the origin of their cytotoxicity.
publishDate 2020
dc.date.none.fl_str_mv 2020-03-06
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10316/106460
https://hdl.handle.net/10316/106460
https://doi.org/10.3390/molecules25051195
url https://hdl.handle.net/10316/106460
https://doi.org/10.3390/molecules25051195
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1420-3049
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833602528224215040